2009Yunnan Journal of Traditional Chinese Medicine and Materia MedicaRequires access

Clinical Effect of Entecavir(ETV) Combined with Anluo Huaxian Pill on the Treatment of Chronic Hepatitis B liver fibrosis Patients

Yong Yuan

Open publisher page 0 citations

Abstract

Objective : To observe the clinical effect of entecavir (etv) combined with Anluo Huaxian Pill on the treatment of chronichepatitis B liver fibrosis patients . Methods : 46 patients were randomly divided into one treatment group and one control group. Thetreatment group was treated with ETVand Anluo Huaxian pill whilethe control group was treated only with ETV.Six months was a courseof treatment . HBV-DNAand liver fibrosis indicators( HA、LN、PCIII、CIV) were observed before and after the treatment . Results : TheHBV-DNAandliver fibrosisindicators of the two groups declined apparently after the treatment .Thelevel of theliver fibrosisindicatorsinthe treatment group was lower than that of the control group. The difference was significance(P0 .01) . Conclusion: The treatment ofETVcombined with Anluo Huaxian pill obviouslyi mproves the levels of the chronic hepatitis Bliver fibrosis patients .

About this research paper

What this paper is about

Objective : To observe the clinical effect of entecavir (etv) combined with Anluo Huaxian Pill on the treatment of chronichepatitis B liver fibrosis patients . Methods : 46 patients were randomly divided into one treatment group and one control group. Thetreatment group was treated with ETVand Anluo Huaxian pill whilethe control group was treated only with ETV.Six months was a courseof treatment . HBV-DNAand liver fibrosis indicators( HA、LN、PCIII、CIV) were observed before and after the treatment . Results : TheHBV-DNAandliver fibrosisindicators of the two groups declined apparently after the treatment .Thelevel of theliver fibrosisindicatorsinthe treatment group was lower than that of the control group. The difference was significance(P0 .01) . Conclusion: The treatment ofETVcombined with Anluo Huaxian pill obviouslyi mproves the levels of the chronic hepatitis Bliver fibrosis patients .

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective : To observe the clinical effect of entecavir (etv) combined with Anluo Huaxian Pill on the treatment of chronichepatitis B liver fibrosis patients . Methods : 46 patients were randomly divided into one treatment group and one control group. Thetreatment group was treated with ETVand Anluo Huaxian pill whilethe control group was treated only with ETV.Six months was a courseof treatment . HBV-DNAand liver fibrosis indicators( HA、LN、PCIII、CIV) were observed before and after the treatment . Results : TheHBV-DNAandliver fibrosisindicators of the two groups declined apparently after the treatment .Thelevel of theliver fibrosisindicatorsinthe treatment group was lower than that of the control group. The difference was significance(P0 .01) . Conclusion: The treatment ofETVcombined with Anluo Huaxian pill obviouslyi mproves the levels of the chronic hepatitis Bliver fibrosis patients .

Key concepts: Entecavir, Medicine, Pill, Gastroenterology, Chronic hepatitis, Internal medicine, Liver fibrosis, Fibrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Effect of Entecavir(ETV) Combined with Anluo Huaxian Pill on the Treatment of Chronic Hepatitis B liver fibrosis Patients — Research Paper | ScholarLens